DAFNA Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.2M | Hold |
|
|||||
2025
Q1 | $16M | Hold |
|
|||||
2024
Q4 | $18.7M | Hold |
|
|||||
2024
Q3 | $21M | Hold |
|
|||||
2024
Q2 | $21.6M | Hold |
|
|||||
2024
Q1 | $27.9M | Sell |
|
|||||
2023
Q4 | $33.4M | Sell |
|
|||||
2023
Q3 | $14.1M | Buy |
|
|||||
2023
Q2 | $10.9M | Buy |
|
|||||
2023
Q1 | $9.73M | Buy |
|
|||||
2022
Q4 | $8.43M | Hold |
|
|||||
2022
Q3 | $8.91M | Sell |
|
|||||
2022
Q2 | $8.31M | Hold |
|
|||||
2022
Q1 | $7.79M | Buy |
|
|||||
2021
Q4 | $6.11M | Sell |
|
|||||
2021
Q3 | $6.25M | Buy |
|
|||||
2020
Q1 | – | Sell |
|
|||||
2019
Q4 | $4.44M | Hold |
|
|||||
2019
Q3 | $4.76M | Sell |
|
|||||
2019
Q2 | $5.37M | Buy |
|
|||||
2019
Q1 | $3.24M | Buy |
|
|||||
2018
Q4 | $1.17M | Buy |
|
|||||
2018
Q3 | $617K | Sell |
|
|||||
2018
Q2 | $576K | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $2.56M | Buy |
|
|||||
2016
Q3 | $1.67M | Buy |
|
|||||
2016
Q2 | $1.42M | Buy |
|
|||||
2016
Q1 | $392K | Buy |
|
|||||
2015
Q4 | $418K | Buy |
|